MEGHAN LAINOFF: Open Payments
NPI 1902454366 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $662 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $117 |
| Organon LLC | 4 | $98 |
| Janssen Biotech, Inc. | 3 | $98 |
| GENZYME CORPORATION | 3 | $81 |
| ABBVIE INC. | 3 | $78 |
| UCB, Inc. | 3 | $68 |
| Incyte Corporation | 2 | $56 |
| Amgen Inc. | 1 | $27 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
Products named: COSENTYX, TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, VTAMA, OPZELURA, OTEZLA.
Industry payments across MD — which companies pay providers there.
